Tumor Necrosis Factor Inhibitor Drugs Market Size, Share, Trends, Value 2030

Tumor Necrosis Factor Inhibitor Drugs Market

Tumor Necrosis Factor Inhibitor Drugs Market by Product (Biosimilars, Cimzia, Simponi/Simponi Aria, Remicade, Enbrel and Humira); by Application (Psoriasis, Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis, Crohn’s Disease, Hidradenitis Suppurativa, Juvenile Idiopathic Arthritis, Ankylosing Spondylitis and Other Applications); By Distribution Channel (Specialty Pharmacies, Hospital Pharmacies and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-5009 Published Date: Nov-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 CAGR (in %) Base Year
USD 40.23 Billion USD 42.08 Billion 0.7% 2018

Tumor Necrosis Factor Inhibitor Drugs Market

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Tumor Necrosis Factor Inhibitor Drugs Market, 2016-2025 (USD Million)
    • 2.2. Tumor Necrosis Factor Inhibitor Drugs Market: Snapshot
  • Chapter 3. Tumor Necrosis Factor Inhibitor Drugs Market - Industry Analysis
    • 3.1. Tumor Necrosis Factor Inhibitor Drugs Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Application
      • 3.6.3. Market attractiveness analysis By Distribution Channel
      • 3.6.4. Market attractiveness analysis By Region
  • Chapter 4. Tumor Necrosis Factor Inhibitor Drugs Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Tumor Necrosis Factor Inhibitor Drugs Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Tumor Necrosis Factor Inhibitor Drugs Market - Product Analysis
    • 5.1. Global Tumor Necrosis Factor Inhibitor Drugs Market overview: By Product
      • 5.1.1. Global Tumor Necrosis Factor Inhibitor Drugs Market share, By Product,2018 and 2025
    • 5.2. Humira
      • 5.2.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Humira, 2016-2025 (USD Million)
    • 5.3. Enbrel
      • 5.3.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Enbrel, 2016-2025 (USD Million)
    • 5.4. Remicade
      • 5.4.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Remicade, 2016-2025 (USD Million)
    • 5.5. Simponi/Simponi Aria
      • 5.5.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Simponi/Simponi Aria, 2016-2025 (USD Million)
    • 5.6. Cimzia
      • 5.6.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Cimzia, 2016-2025 (USD Million)
    • 5.7. Biosimilars
      • 5.7.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Biosimilars, 2016-2025 (USD Million)
  • Chapter 6. Global Tumor Necrosis Factor Inhibitor Drugs Market -Application Analysis
    • 6.1. Global Tumor Necrosis Factor Inhibitor Drugs Market overview: By Application
      • 6.1.1. Global Tumor Necrosis Factor Inhibitor Drugs Market share, By Application, 2018 and 2025
    • 6.2. Rheumatoid Arthritis
      • 6.2.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Rheumatoid Arthritis, 2016-2025 (USD Million)
    • 6.3. Psoriasis
      • 6.3.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Psoriasis, 2016-2025 (USD Million)
    • 6.4. Psoriatic Arthritis
      • 6.4.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Psoriatic Arthritis, 2016-2025 (USD Million)
    • 6.5. Crohn's Disease
      • 6.5.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Crohn's Disease, 2016-2025 (USD Million)
    • 6.6. Ulcerative Colitis
      • 6.6.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Ulcerative Colitis Applications, 2016-2025 (USD Million)
    • 6.7. Ankylosing Spondylitis
      • 6.7.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Ankylosing Spondylitis Applications, 2016-2025 (USD Million)
    • 6.8. Juvenile Idiopathic Arthritis
      • 6.8.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Juvenile Idiopathic Arthritis Applications, 2016-2025 (USD Million)
    • 6.9. Hidradenitis Suppurativa
      • 6.9.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Hidradenitis SuppurativaApplications, 2016-2025 (USD Million)
    • 6.10. Others
      • 6.10.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Other Applications, 2016-2025 (USD Million)
  • Chapter 7. Global Tumor Necrosis Factor Inhibitor Drugs Market -Distribution Channel Analysis
    • 7.1. Global Tumor Necrosis Factor Inhibitor Drugs Market overview: By Distribution Channel
      • 7.1.1. Global Tumor Necrosis Factor Inhibitor Drugs Marketshare, By Distribution Channel, 2018 and 2025
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Hospital Pharmacies, 2016-2025 (USD Million)
    • 7.3. Specialty Pharmacies
      • 7.3.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Specialty Pharmacies, 2016-2025 (USD Million)
    • 7.4. Online Pharmacies
      • 7.4.1. Global Tumor Necrosis Factor Inhibitor Drugs Market By Online Pharmacies, 2016-2025 (USD Million)
  • Chapter 8. Global Tumor Necrosis Factor Inhibitor Drugs Market - Regional Analysis
    • 8.1. Global Tumor Necrosis Factor Inhibitor Drugs Market overview: By Region
    • 8.1.1. Global Tumor Necrosis Factor Inhibitor Drugs Marketshare, By Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Tumor Necrosis Factor Inhibitor Drugs Market, 2016-2025 (USD Million)
      • 8.2.2. North America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.2.3. North America Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Application, 2016-2025 (USD Million)
      • 8.2.4. North America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.5.2. The U.S.Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S.Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. EuropeTumor Necrosis Factor Inhibitor Drugs Market2016-2025 (USD Million)
      • 8.3.2. Europe Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.3.3. Europe Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
      • 8.3.4. Europe Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K.Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.5.2. U.K.Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.6.2. France Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.3.6.3. France Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.7.2. Germany Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Application, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeTumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.8.2. Rest of EuropeTumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Application, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Tumor Necrosis Factor Inhibitor Drugs Market, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Product,2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.5.2. China Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.4.5.3. China Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.6.2. Japan Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Application, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.7.2. India Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Application, 2016-2025 (USD Million)
        • 8.4.7.3. India Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Product,2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Tumor Necrosis Factor Inhibitor Drugs Market, 2016-2025 (USD Million)
      • 8.5.2. Latin America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.5.3. Latin America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
      • 8.5.4. Latin America Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Product,2016-2025 (USD Million)
        • 8.5.5.2. Brazil Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.6. Rest of LatinAmerica
        • 8.5.6.1. Rest of LatinAmerica Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.5.6.2. Rest of LatinAmerica Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Tumor Necrosis Factor Inhibitor Drugs Market, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Product,2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Tumor Necrosis Factor Inhibitor Drugs Market revenue, By Application, 2016-2025 (USD Million)
      • 8.6.4. The Middle East and Africa Tumor Necrosis Factor Inhibitor Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Merck & co., Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Pfizer, Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Novartis International AG
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. UCB S.A.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Johnson & Johnson Services, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Amgen Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. AbbVie Inc.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global tumor necrosis factor inhibitor drugs market, 2016-2025 (USD Million)
4. Porter’s five forces analysis: tumor necrosis factor inhibitor drugs market
5. Global tumor necrosis factor inhibitor drugs market attractiveness, by product
6. Global tumor necrosis factor inhibitor drugs market attractiveness, by application
7. Global tumor necrosis factor inhibitor drugs market attractiveness, by distribution channel
8. Global tumor necrosis factor inhibitor drugs market revenue share, by product, 2018 and 2025
9. Global tumor necrosis factor inhibitor drugs market by Humira, 2016-2025 (USD Million)
10. Global tumor necrosis factor inhibitor drugs market by Enbrel, 2016-2025 (USD Million)
11. Global tumor necrosis factor inhibitor drugs market by Remicade, 2016-2025 (USD Million)
12. Global tumor necrosis factor inhibitor drugs market by Simponi/Simponi Aria, 2016-2025 (USD Million)
13. Global tumor necrosis factor inhibitor drugs market by Cimzia, 2016-2025 (USD Million)
14. Global tumor necrosis factor inhibitor drugs market by Biosimilars, 2016-2025 (USD Million)
15. Global tumor necrosis factor inhibitor drugs market revenue share, by application, 2018 and 2025
16. Global tumor necrosis factor inhibitor drugs market by Rheumatoid Arthritis, 2016-2025 (USD Million)
17. Global tumor necrosis factor inhibitor drugs market by Psoriasis, 2016-2025 (USD Million)
18. Global tumor necrosis factor inhibitor drugs market by Psoriatic Arthritis, 2016-2025 (USD Million)
19. Global tumor necrosis factor inhibitor drugs market by Crohn’s Disease, 2016-2025 (USD Million)
20. Global tumor necrosis factor inhibitor drugs market by Ulcerative Colitis, 2016-2025 (USD Million)
21. Global tumor necrosis factor inhibitor drugs market by Ankylosing Spondylitis, 2016-2025 (USD Million)
22. Global tumor necrosis factor inhibitor drugs market by Juvenile Idiopathic Arthritis, 2016-2025 (USD Million)
23. Global tumor necrosis factor inhibitor drugs market by Hidradenitis Suppurativa, 2016-2025 (USD Million)
24. Global tumor necrosis factor inhibitor drugs market by Other Applications, 2016-2025 (USD Million)
25. Global tumor necrosis factor inhibitor drugs market revenue share, by distribution channel, 2018 and 2025
26. Global tumor necrosis factor inhibitor drugs market by Hospital Pharmacies, 2016-2025 (USD Million)
27. Global tumor necrosis factor inhibitor drugs market by Specialty Pharmacies, 2016-2025 (USD Million)
28. Global tumor necrosis factor inhibitor drugs market by Online Pharmacies, 2016-2025 (USD Million)
29. Global tumor necrosis factor inhibitor drugs market revenue share, by region, 2018 & 2025
30. North America tumor necrosis factor inhibitor drugs market, 2016-2025 (USD Million)
31. Europe tumor necrosis factor inhibitor drugs market, 2016-2025 (USD Million)
32. Asia Pacific tumor necrosis factor inhibitor drugs market, 2016-2025 (USD Million)
33. Latin America tumor necrosis factor inhibitor drugs market, 2016-2025 (USD Million)
34. Middle East & Africa tumor necrosis factor inhibitor drugs market, 2016-2025 (USD Million)
 
 


Table Of Tables

List of Tables

1. Global tumor necrosis factor inhibitor drugs market: snapshot
2. Drivers for tumor necrosis factor inhibitor drugs market: impact analysis
3. Restraints for tumor necrosis factor inhibitor drugs market: impact analysis
4. North America tumor necrosis factor inhibitor drugs market revenue, by country, 2016-2025 (USD Million)
5. North America tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
6. North America tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
7. North America tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
8. The U.S. tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
9. The U.S. tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
10. The U.S. tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
11. Rest of North America tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
12. Rest of North America tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
13. Rest of North America tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
14. Europe tumor necrosis factor inhibitor drugs market revenue, by country, 2016-2025 (USD Million)
15. Europe tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
16. Europe tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
17. Europe tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
18. U.K. tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
19. U.K. tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
20. U.K. tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
21. France tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
22. France tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
23. France tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
24. Germany tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
25. Germany tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
26. Germany tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
27. Rest of Europe tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
28. Rest of Europe tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
29. Rest of Europe tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
30. Asia Pacific tumor necrosis factor inhibitor drugs market revenue, by country, 2016-2025 (USD Million)
31. Asia Pacific tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
32. Asia Pacific tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
33. Asia Pacific tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
34. China tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
35. China tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
36. China tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
37. Japan tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
38. Japan tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
39. Japan tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
40. India tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
41. India tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
42. India tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
43. Rest of Asia Pacific tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
44. Rest of Asia Pacific tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
45. Rest of Asia Pacific tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
46. Latin America tumor necrosis factor inhibitor drugs market revenue, by country, 2016-2025 (USD Million)
47. Latin America tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
48. Latin America tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
49. Latin America tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
50. Brazil tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
51. Brazil tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
52. Brazil tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
53. Rest of Latin America tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
54. Rest of Latin America tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
55. Rest of Latin America tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
56. Middle  East & Africa tumor necrosis factor inhibitor drugs market revenue, by product, 2016-2025 (USD Million)
57. Middle  East & Africa tumor necrosis factor inhibitor drugs market revenue, by application, 2016-2025 (USD Million)
58. Middle  East & Africa tumor necrosis factor inhibitor drugs market revenue, by distribution channel, 2016-2025 (USD Million)
 

Methodology

FrequentlyAsked Questions

Tumor necrosis factor (TNF) inhibitor drugs, also known as TNF blockers or TNF-alpha inhibitors, are a class of medications used to treat various inflammatory conditions. These drugs target a protein called tumor necrosis factor-alpha (TNF-alpha), which is a cytokine produced by the immune system. TNF-alpha plays a significant role in promoting inflammation and is involved in the pathogenesis of several autoimmune and inflammatory diseases.

As of my last knowledge update in September 2021, tumor necrosis factor (TNF) inhibitor drugs are a class of medications used to treat inflammatory conditions such as rheumatoid arthritis, psoriasis, Crohn's disease, and ankylosing spondylitis. The market for these drugs can be influenced by several key factors. Please note that developments might have occurred since then, so it's advisable to consult more recent sources for the latest insights.

global demand for tumor necrosis factor inhibitor drugs market was valued at approximately USD 40.23 billion in 2018, and is expected to generate revenue of around USD 42.08 billion by end of 2025

North America dominated the global tumor necrosis factor inhibitor drugs market in 2018. Strong commercial sales, favorable reimbursement policies, the presence of key players, a large patient pool, and growing awareness are major factors driving the growth in this region. Europe was the second largest regional market in terms of revenue share.

Major players in the tumor necrosis factor inhibitor drugs market are Merck & co., Inc., Pfizer, Inc., Novartis International AG, UCB S.A., Johnson & Johnson Services, Inc., Amgen Inc., and AbbVie Inc. among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed